Terms: = Skin cancer AND FUBP1, FBP, 8880, ENSG00000162613, FUBP
5 results:
1. Peritumoral matrilin-2 staining may be useful in distinguishing basal cell carcinoma from folliculocentric basaloid proliferation.
Wang Z; Lee J; Breen C; Ruenger T; Xiong F; Goreshi R; Lu M; Iwamoto S
J Cutan Pathol; 2022 Jun; 49(6):543-548. PubMed ID: 35274748
[TBL] [Abstract] [Full Text] [Related]
2. Molecular testing in metastatic basal cell carcinoma.
Verkouteren BJA; Wakkee M; van Geel M; van Doorn R; Winnepenninckx VJ; Korpershoek E; Mooyaart AL; Reyners AKL; Terra JB; Aarts MJB; Reinders MGHC; Mosterd K
J Am Acad Dermatol; 2021 Nov; 85(5):1135-1142. PubMed ID: 31870915
[TBL] [Abstract] [Full Text] [Related]
3. New reconstruction algorithm for digital breast tomosynthesis: better image quality for humans and computers.
Rodriguez-Ruiz A; Teuwen J; Vreemann S; Bouwman RW; van Engen RE; Karssemeijer N; Mann RM; Gubern-Merida A; Sechopoulos I
Acta Radiol; 2018 Sep; 59(9):1051-1059. PubMed ID: 29254355
[TBL] [Abstract] [Full Text] [Related]
4. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract] [Full Text] [Related]
5. Folliculocentric basaloid proliferation. The bulge (der Wulst) revisited.
Leshin B; White WL
Arch Dermatol; 1990 Jul; 126(7):900-6. PubMed ID: 2360837
[TBL] [Abstract] [Full Text] [Related]
